Skip to content

Liver fibrosis often progresses rapidly in HIV/HCV co-infected; elevated AST levels best predictor

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Atazanavir safe and effective in HCV-coinfected patients with cirrhosis

Relapse of HCV common in HIV/HCV coinfected patients after liver transplant

Lab markers can predict advanced liver fibrosis in more than 90% of cases in HIV/HCV coinfected

Fatty liver prevalence high with HIV/HCV coinfection: 'use ddI or d4T cautiously'

Liver transplantation can be successful in patients co-infected with HIV and hepatitis B

CROI: Liver fibrosis and noninvasive monitoring tools in HIV/HCV coinfected patients

UK guidelines for liver transplants in HIV-positive patients published